Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing media release dated 17th August, 2023 on the Unaudited Financial Results for the quarter ended June 30, 2023.17-08-2023
17-08-2023
Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Additional Details For Corporate Announcement Filed Dated 14Th August, 2023
This is with reference to our announcement dated 14th August, 2023 filed under Regulation 30 of SEBI (LODR) Regulations, 2015. In this regard, we are hereby submitting additional details as per SEBI Circular dated September 09, 2015, for Outcome of Board Meeting filed under Regulation 30 of SEBI (LODR) Regulations, 2015.17-08-2023
Veerhealth Care Limited - 511523 - Compliance - Statement Of Deviation Or Variation In The Use Of Proceeds Of Preferential Issue
Pursuant to Regulation 32 of the SEBI (LODR) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds of Preferential Issue.14-08-2023
Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation for appointment of Directors of the Company.14-08-2023
Veerhealth Care Limited - 511523 - Financial Results For June 30, 2023
Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclose the following: 1. Statement showing the Unaudited Financial Results for the quarter ended June 30, 2023. 2. Limited Review Report on the Unaudited Financial Results for the quarter ended June 30, 2023.14-08-2023
Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. August 14, 2023 as under: 1. The Board has approved and taken on record the unaudited Financial Results for the quarter ended June 30, 2023. 2. The Board has considered and approved to increase Authorized Share Capital from Rs. 20 crore to Rs. 31 crore and consequent Alteration in Memorandum of Association. 3. The Board has considered and approved issue of Bonus equity shares in the ratio of 1:1 i.e. 1 fully paid up equity share for every 1 fully paid up equity shares held and accordingly fix record date for the purpose of Bonus Issue. 4. The Board has approved Director's Report for the financial year ending 31st March, 2023.14-08-2023
Veerhealth Care Limited - 511523 - Board Meeting Intimation for Notice Of The Meeting Of The Board Of Directors
Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve 1. To consider and approve unaudited financial results of the Company for the quarter ended 30th June, 2023. 2. To increase Authorized Share Capital of the Company. 3. To issue Bonus Shares to the equity shareholders of the Company. 4. To approve draft Director's Report for the financial year ending 31st March, 2023. 5. To approve the draft notice convening 31st Annual General Meeting of the Company. 6. To fix Book Closure date. 7. To appoint a Director in place of Mr. Yogesh Shah, who retires by rotation. 8. Any other business with permission of the Chair. Further to our intimation to the Stock Exchange vide our letter dated June 30, 2023 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of the Company which was closed from July 01, 2023 will be opened on August 17, 2023 as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015.04-08-2023
Veerhealth Care Limited - 511523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate received from RTA for the quarter ended 30th June, 2023.08-07-2023
Veerhealth Care Limited - 511523 - Closure of Trading Window
This is to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, we wish to inform that the trading window for dealing in securities of the Company will remain closed from the end of quarter ended 30th June, 2023 till 48 hours after the declaration of financial results.30-06-2023
Veerhealth Care Limited - 511523 - Additional Details For Corporate Announcement Filed Dated 12Th June, 2023 Under Regulation 30 Of SEBI (LODR) Regulations, 2015
This is with reference to our announcement dated 12th June, 2023 filed under Regulation 30 of SEBI (LODR) Regulations, 2015. In this regard, we are hereby submitting additional details as per SEBI Circular dated September 09, 2015, for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015.13-06-2023